IFNB1 and relapsing-remitting multiple sclerosis: The first DMTs approved for relapsing-remitting MS (RR-MS) prophylaxis were the interferons-beta (IFNβ) and glatiramer acetate (GA), which remain first-line drugs, followed by other agents like natalizumab, mitoxantrone, and fingolimod, assigned as second-line treatments.